"Vulnerable plaques" - Ticking of the time bomb

Amit K. Mitra, Ashwini S. Dhume, Devendra K. Agrawal

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Atherosclerosis and its sequelae are one of the leading causes of morbidity and mortality, especially in the developed nations. Over the years, treatment protocols have changed with the changing understanding of the disease process. Inflammatory mechanisms have emerged as key players in the formation of the atherosclerotic plaque. For the majority of its life span, the plaque develops silently and only some exhibit overt clinical manifestations. The purpose of this review is to examine the inherent properties of some of these "vulnerable" or symptomatic plaques. Rupture of the plaque is related to the thickness of the fibrous cap overlying the necrotic lipid core. A thin cap is more likely to lead to rupture. Multiple factors broadly grouped as the "determinants of vulnerability" are responsible for directly or indirectly influencing the plaque dynamics. Apoptosis is considered an important underlying mechanism that contributes to plaque instability. Inflammatory reactions within the plaque trigger apoptosis by cell-cell contact and intracellular death signaling. Once started, the apoptotic process affects all of the components that make up the plaque, including vascular smooth muscle cells, endothelial cells, and macrophages. Extensive research has identified many of the key cellular and molecular regulators that play a part in apoptosis within the atherosclerotic lesion. This information will help us to gain a better understanding of the underlying mechanisms at the cellular and molecular level and enable us to formulate better therapeutic strategies to combat this disease.

Original languageEnglish
Pages (from-to)860-871
Number of pages12
JournalCanadian Journal of Physiology and Pharmacology
Volume82
Issue number10
DOIs
StatePublished - Oct 2004

Fingerprint

Apoptosis
Rupture
Atherosclerotic Plaques
Clinical Protocols
Vascular Smooth Muscle
Developed Countries
Smooth Muscle Myocytes
Atherosclerosis
Endothelial Cells
Macrophages
Morbidity
Lipids
Mortality
Research
Therapeutics

All Science Journal Classification (ASJC) codes

  • Physiology
  • Pharmacology

Cite this

"Vulnerable plaques" - Ticking of the time bomb. / Mitra, Amit K.; Dhume, Ashwini S.; Agrawal, Devendra K.

In: Canadian Journal of Physiology and Pharmacology, Vol. 82, No. 10, 10.2004, p. 860-871.

Research output: Contribution to journalArticle

Mitra, Amit K. ; Dhume, Ashwini S. ; Agrawal, Devendra K. / "Vulnerable plaques" - Ticking of the time bomb. In: Canadian Journal of Physiology and Pharmacology. 2004 ; Vol. 82, No. 10. pp. 860-871.
@article{1fdfa930c23243f284faddf2bdf3cd04,
title = "{"}Vulnerable plaques{"} - Ticking of the time bomb",
abstract = "Atherosclerosis and its sequelae are one of the leading causes of morbidity and mortality, especially in the developed nations. Over the years, treatment protocols have changed with the changing understanding of the disease process. Inflammatory mechanisms have emerged as key players in the formation of the atherosclerotic plaque. For the majority of its life span, the plaque develops silently and only some exhibit overt clinical manifestations. The purpose of this review is to examine the inherent properties of some of these {"}vulnerable{"} or symptomatic plaques. Rupture of the plaque is related to the thickness of the fibrous cap overlying the necrotic lipid core. A thin cap is more likely to lead to rupture. Multiple factors broadly grouped as the {"}determinants of vulnerability{"} are responsible for directly or indirectly influencing the plaque dynamics. Apoptosis is considered an important underlying mechanism that contributes to plaque instability. Inflammatory reactions within the plaque trigger apoptosis by cell-cell contact and intracellular death signaling. Once started, the apoptotic process affects all of the components that make up the plaque, including vascular smooth muscle cells, endothelial cells, and macrophages. Extensive research has identified many of the key cellular and molecular regulators that play a part in apoptosis within the atherosclerotic lesion. This information will help us to gain a better understanding of the underlying mechanisms at the cellular and molecular level and enable us to formulate better therapeutic strategies to combat this disease.",
author = "Mitra, {Amit K.} and Dhume, {Ashwini S.} and Agrawal, {Devendra K.}",
year = "2004",
month = "10",
doi = "10.1139/y04-095",
language = "English",
volume = "82",
pages = "860--871",
journal = "Canadian Journal of Physiology and Pharmacology",
issn = "0008-4212",
publisher = "National Research Council of Canada",
number = "10",

}

TY - JOUR

T1 - "Vulnerable plaques" - Ticking of the time bomb

AU - Mitra, Amit K.

AU - Dhume, Ashwini S.

AU - Agrawal, Devendra K.

PY - 2004/10

Y1 - 2004/10

N2 - Atherosclerosis and its sequelae are one of the leading causes of morbidity and mortality, especially in the developed nations. Over the years, treatment protocols have changed with the changing understanding of the disease process. Inflammatory mechanisms have emerged as key players in the formation of the atherosclerotic plaque. For the majority of its life span, the plaque develops silently and only some exhibit overt clinical manifestations. The purpose of this review is to examine the inherent properties of some of these "vulnerable" or symptomatic plaques. Rupture of the plaque is related to the thickness of the fibrous cap overlying the necrotic lipid core. A thin cap is more likely to lead to rupture. Multiple factors broadly grouped as the "determinants of vulnerability" are responsible for directly or indirectly influencing the plaque dynamics. Apoptosis is considered an important underlying mechanism that contributes to plaque instability. Inflammatory reactions within the plaque trigger apoptosis by cell-cell contact and intracellular death signaling. Once started, the apoptotic process affects all of the components that make up the plaque, including vascular smooth muscle cells, endothelial cells, and macrophages. Extensive research has identified many of the key cellular and molecular regulators that play a part in apoptosis within the atherosclerotic lesion. This information will help us to gain a better understanding of the underlying mechanisms at the cellular and molecular level and enable us to formulate better therapeutic strategies to combat this disease.

AB - Atherosclerosis and its sequelae are one of the leading causes of morbidity and mortality, especially in the developed nations. Over the years, treatment protocols have changed with the changing understanding of the disease process. Inflammatory mechanisms have emerged as key players in the formation of the atherosclerotic plaque. For the majority of its life span, the plaque develops silently and only some exhibit overt clinical manifestations. The purpose of this review is to examine the inherent properties of some of these "vulnerable" or symptomatic plaques. Rupture of the plaque is related to the thickness of the fibrous cap overlying the necrotic lipid core. A thin cap is more likely to lead to rupture. Multiple factors broadly grouped as the "determinants of vulnerability" are responsible for directly or indirectly influencing the plaque dynamics. Apoptosis is considered an important underlying mechanism that contributes to plaque instability. Inflammatory reactions within the plaque trigger apoptosis by cell-cell contact and intracellular death signaling. Once started, the apoptotic process affects all of the components that make up the plaque, including vascular smooth muscle cells, endothelial cells, and macrophages. Extensive research has identified many of the key cellular and molecular regulators that play a part in apoptosis within the atherosclerotic lesion. This information will help us to gain a better understanding of the underlying mechanisms at the cellular and molecular level and enable us to formulate better therapeutic strategies to combat this disease.

UR - http://www.scopus.com/inward/record.url?scp=13544268490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13544268490&partnerID=8YFLogxK

U2 - 10.1139/y04-095

DO - 10.1139/y04-095

M3 - Article

VL - 82

SP - 860

EP - 871

JO - Canadian Journal of Physiology and Pharmacology

JF - Canadian Journal of Physiology and Pharmacology

SN - 0008-4212

IS - 10

ER -